FairJourney Bio opened a new cryo-electron microscopy (cryo-EM) structural biology facility in San Diego, expanding its U.S. footprint and integrating atomic-resolution structure capabilities into its antibody discovery platform. The facility houses two ThermoFisher Titan Krios 5 systems and supports native-state structure determination of antibody-target complexes. The new site is designed to strengthen end-to-end discovery workflows, including epitope mapping, hit generation, and structure-guided lead optimization. By adding atomic-resolution capabilities earlier in the pipeline, FairJourney is positioning structural biology as a decision-shaping tool rather than a late-stage confirmation step. The move also signals continued demand for high-end analytical capacity among biotechs that lack in-house structural biology infrastructure. For clients, it can translate into faster iteration cycles and improved confidence in lead selection. With services launched earlier in 2026, the San Diego expansion also reflects ongoing competition among CROs to provide near-real-time structural insights for antibody and biologic development.